Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality Assurance

Current Problems in Cancer

Volumn 36, Issue 4, 2012, Pages 183-190

  Park, Henry S ^a   Lloyd, Shane ^a   Decker, Roy H ^a   Wilson, Lynn D ^a   Yu, James B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CHORIONIC GONADOTROPIN; ESTROGEN RECEPTOR; LACTATE DEHYDROGENASE; PROGESTERONE RECEPTOR;

ADJUVANT CHEMOTHERAPY; AGE DISTRIBUTION; ARTICLE; BRACHYTHERAPY; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; DEMOGRAPHY; EDUCATIONAL STATUS; EXTERNAL BEAM RADIOTHERAPY; EXTERNAL VALIDITY; FOLLOW UP; GEOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAID; MEDICARE; POVERTY; QUALITY CONTROL; QUALITY OF LIFE; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; SEER PROGRAM; UNITED STATES;

EID: 84864304314     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2012.03.007     Document Type: Article

References (11)

1. About the SEER program National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/about.
2. SEER: surveillance, epidemiology, and end results program National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/about/SEER_brochure.pdf.
3. Population characteristics National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/registries/characteristics.html.
4. SEER research data record description: cases diagnosed in 1973-2008 National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/manuals/TextData.FileDescription.pdf.
5. Standard populations (millions) for age-adjustment National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/stdpopulations/index.html.
6. Time frames considerations in staging National Cancer Institute, Accessed October 16, 2011. http://training.seer.cancer.gov/staging/time.html.
7. US mortality data National Cancer Institute, Accessed October 16, 2011. http://seer.cancer.gov/mortality/index.html.
8. Warren J.L., Klabunde C.N., Schrag D., et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002, 40(suppl 8):IV-3-IV-18.
9. Ambs A., Warren J.L., Bellizzi K.M., et al. Overview of the SEER-Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev 2008, 29:5-21.
10. Clegg L.X., Reichman M.E., Miller B.A., et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009, 20:417-435.
11. Szklo M. Population-based cohort studies. Epidemiol Rev 1998, 20:81-90.